These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 33092235)

  • 21. Circulating tumor cell levels are elevated in colorectal cancer patients with high tumor burden in the liver.
    Kaifi JT; Kunkel M; Dicker DT; Joude J; Allen JE; Das A; Zhu J; Yang Z; Sarwani NE; Li G; Staveley-O'Carroll KF; El-Deiry WS
    Cancer Biol Ther; 2015; 16(5):690-8. PubMed ID: 25785486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Whole blood ACTB, B2M and GAPDH expression reflects activity of inflammatory bowel disease, advancement of colorectal cancer, and correlates with circulating inflammatory and angiogenic factors: Relevance for real-time quantitative PCR.
    Bednarz-Misa I; Neubauer K; Zacharska E; Kapturkiewicz B; Krzystek-Korpacka M
    Adv Clin Exp Med; 2020 May; 29(5):547-556. PubMed ID: 32424999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early Assessment of Colorectal Cancer by Quantifying Circulating Tumor Cells in Peripheral Blood: ECT2 in Diagnosis of Colorectal Cancer.
    Chen CJ; Sung WW; Chen HC; Chern YJ; Hsu HT; Lin YM; Lin SH; Peck K; Yeh KT
    Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28362321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterogeneity of epidermal growth factor receptor status and mutations of KRAS/PIK3CA in circulating tumor cells of patients with colorectal cancer.
    Gasch C; Bauernhofer T; Pichler M; Langer-Freitag S; Reeh M; Seifert AM; Mauermann O; Izbicki JR; Pantel K; Riethdorf S
    Clin Chem; 2013 Jan; 59(1):252-60. PubMed ID: 23136247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell Heterogeneity Analysis in Single-Cell RNA-seq Data Using Mixture Exponential Graph and Markov Random Field Model.
    Wang Y; Tian X; Ai D
    Biomed Res Int; 2021; 2021():9919080. PubMed ID: 34095314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients.
    Pestrin M; Salvianti F; Galardi F; De Luca F; Turner N; Malorni L; Pazzagli M; Di Leo A; Pinzani P
    Mol Oncol; 2015 Apr; 9(4):749-57. PubMed ID: 25539732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of intrapatient heterogeneity of circulating tumor cells at the single-cell level in the cerebrospinal fluid of a patient with metastatic gastric cancer.
    Cho JH; Sim MH; Kim SY; Kim K; Lee T; Lee J; Kang WK; Kim ST
    J Cancer Res Ther; 2021; 17(4):1047-1051. PubMed ID: 34528562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations between the cyclooxygenase-2 expression in circulating tumor cells and the clinicopathological features of patients with colorectal cancer.
    Cai J; Huang L; Huang J; Kang L; Lin H; Huang P; Zhu P; Wang J; Dong J; Wang L; Xian CJ
    J Cell Biochem; 2019 Apr; 120(4):4935-4941. PubMed ID: 30260024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of disrupted pathways in ulcerative colitis-related colorectal carcinoma by systematic tracking the dysregulated modules.
    Wu D; Li Q; Song G; Lu J
    J BUON; 2016; 21(2):366-74. PubMed ID: 27273946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Potential of Circulating Tumor Cells in Colorectal Cancer: A Prospective Study.
    Baek DH; Kim GH; Song GA; Han IS; Park EY; Kim HS; Jo HJ; Ko SH; Park DY; Cho YK
    Clin Transl Gastroenterol; 2019 Jul; 10(7):e00055. PubMed ID: 31246593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Global gene expression profiling of circulating tumor cells.
    Smirnov DA; Zweitzig DR; Foulk BW; Miller MC; Doyle GV; Pienta KJ; Meropol NJ; Weiner LM; Cohen SJ; Moreno JG; Connelly MC; Terstappen LW; O'Hara SM
    Cancer Res; 2005 Jun; 65(12):4993-7. PubMed ID: 15958538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer.
    Cohen SJ; Alpaugh RK; Gross S; O'Hara SM; Smirnov DA; Terstappen LW; Allard WJ; Bilbee M; Cheng JD; Hoffman JP; Lewis NL; Pellegrino A; Rogatko A; Sigurdson E; Wang H; Watson JC; Weiner LM; Meropol NJ
    Clin Colorectal Cancer; 2006 Jul; 6(2):125-32. PubMed ID: 16945168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-17A modulates circulating tumor cells in tumor draining vein of colorectal cancers and affects metastases.
    Tseng JY; Yang CY; Liang SC; Liu RS; Yang SH; Lin JK; Chen YM; Wu YC; Jiang JK; Lin CH
    Clin Cancer Res; 2014 Jun; 20(11):2885-97. PubMed ID: 24677375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell-Free RNA Content in Peripheral Blood as Potential Biomarkers for Detecting Circulating Tumor Cells in Non-Small Cell Lung Carcinoma.
    Yu XM; Wu YC; Liu X; Huang XC; Hou XX; Wang JL; Cheng XL; Mao WM; Ling ZQ
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27827952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Profiling protein expression in circulating tumour cells using microfluidic western blotting.
    Sinkala E; Sollier-Christen E; Renier C; Rosàs-Canyelles E; Che J; Heirich K; Duncombe TA; Vlassakis J; Yamauchi KA; Huang H; Jeffrey SS; Herr AE
    Nat Commun; 2017 Mar; 8():14622. PubMed ID: 28332571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The presence of clustered circulating tumor cells (CTCs) and circulating cytokines define an aggressive phenotype in metastatic colorectal cancer.
    Divella R; Daniele A; Abbate I; Bellizzi A; Savino E; Simone G; Giannone G; Giuliani F; Fazio V; Gadaleta-Caldarola G; Gadaleta CD; Lolli I; Sabbà C; Mazzocca A
    Cancer Causes Control; 2014 Nov; 25(11):1531-41. PubMed ID: 25135616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing.
    Heitzer E; Auer M; Gasch C; Pichler M; Ulz P; Hoffmann EM; Lax S; Waldispuehl-Geigl J; Mauermann O; Lackner C; Höfler G; Eisner F; Sill H; Samonigg H; Pantel K; Riethdorf S; Bauernhofer T; Geigl JB; Speicher MR
    Cancer Res; 2013 May; 73(10):2965-75. PubMed ID: 23471846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer.
    Davis AA; Zhang Q; Gerratana L; Shah AN; Zhan Y; Qiang W; Finkelman BS; Flaum L; Behdad A; Gradishar WJ; Platanias LC; Cristofanilli M
    Breast Cancer Res; 2019 Dec; 21(1):137. PubMed ID: 31801599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of isolated circulating tumor cells and tissue biopsies using whole-genome sequencing in prostate cancer.
    Jiang R; Lu YT; Ho H; Li B; Chen JF; Lin M; Li F; Wu K; Wu H; Lichterman J; Wan H; Lu CL; OuYang W; Ni M; Wang L; Li G; Lee T; Zhang X; Yang J; Rettig M; Chung LW; Yang H; Li KC; Hou Y; Tseng HR; Hou S; Xu X; Wang J; Posadas EM
    Oncotarget; 2015 Dec; 6(42):44781-93. PubMed ID: 26575023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating tumor cells in different stages of colorectal cancer.
    Eliasova P; Pinkas M; Kolostova K; Gurlich R; Bobek V
    Folia Histochem Cytobiol; 2017; 55(1):1-5. PubMed ID: 28509310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.